Download as pdf or txt
Download as pdf or txt
You are on page 1of 2

MI DT ER MS

PUBLIC HEALTH PHARMACY


PHARM 325

UNIT 5 : IMPROVING PUBLIC HEALTH THROUGH PHARMACY


OUTLINE PHILIPPINE PHARMACISTS ASSOCIATION: 10
I. Topic ADVOCACIES
A. Subtopic
1. Subsubtopic  Pharmacy-based immunization
II. Text box  Pharmaceutical supply chain Management
A. Color: Darkest  Antimicrobial stewardship
B. Outline Weight: 1/2  Pharmacy DOTS initiative
 RPH for mental health
RESPONSIBILITIES OF PHARMACISTS  Medication adherence
 Patient Safety:  Pharmacy information services
o Rational Use of Medicine  Disaster management
o Antimicrobial resistance and antimicrobial  PharmaCEASE: smoking cessation
stewardship  RPh for wellness and self-care
o Immunization Techniques and Safe
Administration of Vaccines MANAGEMENT OF DISEASES

E
o Adverse Events Following Immunization  PERSON BASED APPROACH (PBA)
o Safety Assessment of Cosmetics  adapts and integrates methods from user-
o Quality Risk Management centered design and in-depth qualitative
 Disaster Risk Reduction and Management research to enable a deep understanding of:
 Counterfeit Medicine and SSFFC SSFFC: o the views of the intervention users


o Substandard, Spurious, Falsely labeled,
Falsified and Counterfeit medical products
Pharmaceutical Supply Chain Management
K o the contexts within which they are
engaging with the
intervention/behavioral change o
their experiences of using the
C
intervention
 this understanding then informs the planning,
optimization and evaluation of behavioral health
LO

interventions, ensuring that interventions are


maximally meaningful, engaging and feasible for
all users.

 RECOVERY BASED APPROACH (RBA)


 a strength-based approach that does not focus
solely on symptoms and which emphasizes
B

resilience and control over life's challenges


 refers to the application of sets of capabilities
that support people to recognize and take
responsibility for their own recovery and
wellbeing and to define their goals, wishes and
aspirations
 Capabilities for recovery-oriented practice and
service delivery encompass underlying core
principles, values, knowledge, attitudes and
Figure 1. Responsibilities of a Public Health Pharmacist behaviors, skills and abilities. Individuals, teams
and organizations need these capabilities in
order to support people with health issues to live
CURRENT EXISTING DRUG AND NON-DRUG a meaningful and contributing life in their
RELATED PUBLIC HEALTH POLICIES AND community of choice.
PROGRAMS  Attaining and strengthening these capabilities is
 TB DOTS an ongoing process that takes time and
 Diabetes Control commitment from leaders, professionals, staff
 Smoking Cessation initiatives and volunteers in health service provision.
 Antimicrobial Stewardship programs
 Programs against Substance Abuse
 Reproductive Health programs
 Other DOH health programs

LAST NAME, F.N. 1


UNIT 5: IMPROVING PUBLIC HEALTH THROUGH PHARMACY

 SHARED DECISION MAKING (SDM)


 an approach where clinicians and patients share
the best available evidence when faced with the
task of making decisions, and where patients are
supported to consider options, to achieve informed
preferences
 offers a structured process to incorporate evidence
as well as patient values and preferences into
screening decisions
 most relevant when there is a close trade-off
between the harms and the benefits of a screening
decision that could be altered by individual patient
values and preferences
 the core elements are o risk communication o
values clarification

E
K
Figure 2.
C
ADDITIONAL NOTES
 Values clarification considers both patient values
LO

and patient preferences.


 Preferences are inclinations toward or away from
an option. Values are the underlying feelings that help
determine preferences
 Patient decision aids are knowledge translation
tools that facilitate SDM, but individuals might require
more than one office visit to arrive at a decision about
B

intervention.

END OF MIDTERMS.

Reference(s):
APA Format

Handout & Discussion: RSLumang-ayRPHMSPharm©


MAMenecioRPhMSPharm©2020

LAST NAME, F.N. 2

You might also like